The vaccine for human papillomavirus got a bad rap when it debuted. And yet time has shown it's very effective in reducing cancers linked to HPV.
Many men who have sex with men who cited low HIV risk as a reason for not wanting to start PrEP actually had key HIV risk factors, according to results of a cross-sectional survey analysis.
PrEP's success should not be measured by quantity but by quality. The basic level of health care accessibility should allow people high-quality health care provided by premiere providers and frontline staff.